Sold as Osteolite, Technetium TC-99M Medronate, Cis-Mdp, Technetium TC 99M Mpi Mdp, Amerscan Mdp. Every FDA application for this active ingredient.
As of Nov 22, 2026, FDA lists 5 applications for Technetium TC-99M medronate kit (sold as Osteolite, Technetium TC-99M Medronate, Cis-Mdp and others), first approved Dec 16, 1977, with 0 new uses approved and 0 published complete response letters.
| Dec 16, 1977 | OsteoliteNDA 17972 · New formulation or manufacturer | Sun Pharmaceutical Industries | 12 | Discontinued |
| Jun 26, 1979 | Technetium TC 99M Mpi MdpNDA 18141 · New formulation or manufacturer | GE Healthcare | 21 | Discontinued |
| Aug 29, 1979 | Cis-MdpNDA 18124 · New formulation or manufacturer | Sun Pharmaceutical Industries | 15 | Marketed |
| Feb 17, 1981 | Technetium TC-99M MedronateNDA 18107 · New formulation or manufacturer | Cardinal Health 414 | 14 | Marketed |
| Aug 5, 1982 | Amerscan MdpNDA 18335 · New formulation or manufacturer | GE Healthcare | 2 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Mechanisms, targets, withdrawals and boxed warnings are from ChEMBL (EMBL-EBI, CC BY-SA 3.0), matched by ingredient name. How trials ended is TrialPanorama's classification of ClinicalTrials.gov records (Wang et al. 2025, Apache-2.0), matched by the intervention name each trial registered. Drugs@FDA